RenovoRx Expands RenovoCath Patent Protection for Cancer
Mountain View, California, U.S. | August 20, 2026 RenovoRx announced that the U.S. Patent and Trademark Office (USPTO) has...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Mountain View, California, U.S. | August 20, 2026 RenovoRx announced that the U.S. Patent and Trademark Office (USPTO) has...
CAESAREA, Israel, August 13, 2026 Nitinotes Ltd., a medical device company developing automated endoluminal suturing technologies for obesity treatment,...
Redwood City, California, August,11, 2026 Galvanize Therapeutics, Inc. has announced the completion of the first commercial procedures using its...
BENGALURU, Karnataka, India, July 29, 2026 Biocon Limited has announced that its Canadian subsidiary has received Health Canada Notice...
CAESAREA, Israel, July 29, 2026 IceCure Medical Ltd. has announced a significant development that could broaden the role of...
MINNEAPOLIS, Minn., July 13, 2026 HistoSonics has achieved a major international regulatory milestone after receiving CE Mark approval for...
ARC-SUR-TILLE, France, July 6, 2026 Movmedix, the French orthopedic medical technology company behind the globally recognized LARS® synthetic ligament...
CAESAREA, Israel, July 6, 2026 IceCure Medical Ltd. has announced accelerating commercial adoption of its ProSenseâ„¢ cryoablation system in...
Woburn, Massachusetts | April 13, 2026 Sirtex Medical has announced groundbreaking results from its DOORwaY90 clinical study, demonstrating 100%...
Queensbury, New York, USA, April 6, 2026 ESMO Guideline Inclusion Validates CHEMOSAT Therapy In a major milestone for interventional...
